title: In reply to 'Primary objective of study of sitagliptin in patients with ESRD on dialysis'.
authors: Wendy L
authors: WL
authors: St Peter
authors: Eric D
authors: ED
authors: Weinhandl
authors: Michael F
authors: MF
authors: Flessner
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D006801:Humans; D011719:Pyrazines / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D011719:Pyrazines; D014230:Triazoles